Sale!

JAK2 Mutation Detection RNA Detection Qualitative Test

Original price was: $276.Current price is: $234.

-15%

The JAK2 Mutation Detection RNA Detection Qualitative Test is a specialized genetic analysis that identifies mutations in the Janus Kinase 2 gene using RNA detection methods. This test is crucial for diagnosing and monitoring myeloproliferative neoplasms (MPNs) such as polycythemia vera, essential thrombocythemia, and primary myelofibrosis. By detecting specific JAK2 mutations through qualitative RNA analysis, healthcare providers can confirm diagnoses, guide treatment decisions, and monitor disease progression. The test costs $234 USD and provides results within 24-36 hours, offering patients and physicians valuable insights for managing blood disorders effectively.

Clinically Validated & Lab Certified

  • ISO-Accredited Laboratory, Ensuring Highest Standards
  • Trusted by Hospitals & Patients —Accredited Testing with Results
  • Direct Healthcare Provider Support + Comprehensive Reporting
Guaranteed Safe Checkout

JAK2 Mutation Detection RNA Detection Qualitative Test

Comprehensive Introduction to JAK2 Mutation Testing

The JAK2 Mutation Detection RNA Detection Qualitative Test represents a cutting-edge genetic diagnostic tool that plays a vital role in identifying and managing blood disorders. This sophisticated molecular test specifically targets mutations in the Janus Kinase 2 (JAK2) gene, which serves as a critical biomarker for various myeloproliferative neoplasms. The importance of this test lies in its ability to provide definitive diagnostic information that directly impacts treatment strategies and patient outcomes.

JAK2 mutations are particularly significant because they result in continuous activation of signaling pathways that regulate blood cell production. When these pathways remain constantly active, they lead to uncontrolled proliferation of blood cells, creating the foundation for serious hematological conditions. Our qualitative RNA detection approach ensures the highest level of accuracy in identifying these genetic abnormalities.

What the Test Measures and Detects

This advanced genetic test specifically identifies:

  • JAK2 V617F mutation – the most common mutation associated with myeloproliferative neoplasms
  • Other JAK2 exon 12 mutations that may be present
  • Qualitative detection of JAK2 mutations through RNA analysis
  • Genetic markers indicating abnormal JAK-STAT signaling pathway activation

The test utilizes Real-Time PCR technology to amplify and detect specific RNA sequences, providing a highly sensitive and specific analysis of JAK2 mutation status. This method ensures reliable detection even when mutation levels are low, making it an invaluable tool for early diagnosis and monitoring.

Who Should Consider This Test

Clinical Indications and Symptoms

This test is recommended for individuals experiencing symptoms or clinical findings suggestive of myeloproliferative disorders, including:

  • Unexplained elevated hemoglobin or hematocrit levels
  • Persistent thrombocytosis (high platelet count)
  • Unexplained splenomegaly (enlarged spleen)
  • Constitutional symptoms such as night sweats, weight loss, or fever
  • Pruritus (itching) after bathing
  • Erythromelalgia (burning pain in hands and feet)
  • Thrombotic or hemorrhagic complications
  • Abnormal bone marrow findings

Patient Populations

  • Patients with suspected polycythemia vera
  • Individuals with essential thrombocythemia concerns
  • Those being evaluated for primary myelofibrosis
  • Patients with unexplained blood count abnormalities
  • Individuals with family history of myeloproliferative disorders

Benefits of JAK2 Mutation Testing

Undergoing JAK2 Mutation Detection offers numerous clinical advantages:

  • Accurate Diagnosis: Provides definitive confirmation of myeloproliferative neoplasms
  • Treatment Guidance: Helps physicians select appropriate targeted therapies
  • Prognostic Information: Offers insights into disease progression and outcomes
  • Early Detection: Enables intervention before complications develop
  • Monitoring Capability: Allows tracking of treatment response and disease status
  • Family Risk Assessment: Provides information about potential genetic predisposition

Understanding Your Test Results

Interpretation Guidelines

Your JAK2 Mutation Detection results will fall into one of two categories:

Positive Result

A positive result indicates the presence of JAK2 mutation, which strongly supports the diagnosis of a myeloproliferative neoplasm. This finding typically requires:

  • Consultation with a hematologist or oncology specialist
  • Additional testing to determine the specific type of MPN
  • Development of a comprehensive treatment plan
  • Regular monitoring for disease progression and complications

Negative Result

A negative result suggests the absence of detectable JAK2 mutations, but does not completely rule out myeloproliferative disorders. Further evaluation may include:

  • Testing for other genetic mutations (CALR, MPL)
  • Additional hematological investigations
  • Bone marrow examination if clinically indicated
  • Continued monitoring for developing symptoms

Clinical Correlation

It’s essential to understand that test results should always be interpreted in the context of your complete clinical picture, including symptoms, physical findings, and other laboratory results. Your healthcare provider will integrate this genetic information with your overall health status to make informed decisions about your care.

Test Information and Pricing

Test Component Details
Test Name JAK2 Mutation Detection RNA Detection Qualitative Test
Regular Price $276 USD
Discount Price $234 USD
Sample Type Peripheral Whole Blood
Turnaround Time 3rd Working Day Email: 36 hours | On Phone: 24 hours
Methodology Real Time PCR
Specialty Genetics

Pre-Test Instructions

To ensure accurate results, please follow these preparation guidelines:

  • Sign the required Consent document before testing
  • Bring any available clinical history of the patient
  • No fasting required for this test
  • Inform your healthcare provider about current medications
  • Maintain normal hydration before sample collection

Nationwide Availability

GGC DNA has testing facilities conveniently located across the United States, serving patients in all major metropolitan areas including:

  • New York City and surrounding regions
  • Los Angeles and Southern California
  • Chicago and the Midwest
  • Houston and Texas areas
  • Phoenix and Arizona regions
  • And many more locations nationwide

Take Action for Your Health

Don’t wait to get the answers you need about potential blood disorders. Early detection of JAK2 mutations can significantly impact your treatment outcomes and quality of life. Our experienced genetic specialists are ready to provide you with comprehensive testing and clear, understandable results.

Ready to schedule your JAK2 Mutation Detection Test?

Call us today at +1(267) 388-9828 to book your appointment or speak with our genetic counseling team. We’re available to answer your questions and help you understand the testing process.

You can also WhatsApp us at the same number for quick responses to your inquiries. Our team is committed to providing personalized care and ensuring you have all the information needed to make informed decisions about your health.

Take the first step toward understanding your genetic health – contact GGC DNA today and schedule your JAK2 Mutation Detection RNA Detection Qualitative Test for only $234 USD.